Home > News > Starpharma Continues to Look Good
March 5th, 2006
Starpharma Continues to Look Good
Abstract:
Jack Uldrich: Since my book went to press, two developments have occurred that have served to heighten my optimism about Starpharma’s long-term potential. The first occurred in December when the U.S government granted the Australian company a $20 million grant to expediate its FDA (Food and Drug Administration) approval process for a nanotechnology-based treatment designed to prevent HIV and genital herpes.
Source:
NanoNovus
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||